Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asish K Saha

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Frontiers in Nutrition|August 27, 2021
Dietary Control of Inflammation and ResolutionBarry Sears, Asish K Saha
Molecular and Cellular Biochemistry|November 19, 2003
Malonyl-CoA and AMP-activated protein kinase: an expanding partnershipAsish K Saha, Neil B Ruderman
Obesity (Silver Spring, Md.)|April 29, 2006
Metabolic syndrome: adenosine monophosphate-activated protein kinase and malonyl coenzyme ANeil B Ruderman, Asish K Saha
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry|May 13, 2020
Dietary Technologies to Optimize Healing from Injury-Induced InflammationBarry Sears, Mary Perry, Asish K Saha
Endocrinology|September 23, 2003
Minireview: malonyl CoA, AMP-activated protein kinase, and adiposityNeil B Ruderman, Asish K Saha, Edward W Kraegen
Diabetes/Metabolism Research and Reviews|July 12, 2002
Regulation of muscle malonyl-CoA levels in the nutritionally insulin-resistant desert gerbil, Psammomys obesusEleazar Shafrir, Ehud Ziv, Asish K Saha, et al.
Trends in Pharmacological Sciences|February 1, 2005
AMPK, the metabolic syndrome and cancerZhijun Luo, Asish K Saha, Xiaoqin Xiang, et al.
Diabetes|June 9, 2009
Activation of AMP-activated protein kinase by interleukin-6 in rat skeletal muscle: association with changes in cAMP, energy state, and endogenous fuel mobilizationMeghan Kelly, Marie-Soleil Gauthier, Asish K Saha, et al.
Journal of Endocrinology, Diabetes & Obesity|June 30, 2015
Nutrient Excess in AMPK Downregulation and Insulin ResistanceKimberly A Coughlan, Rudy J Valentine, Neil B Ruderman, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|July 15, 2014
AMPK activation: a therapeutic target for type 2 diabetes?Kimberly A Coughlan, Rudy J Valentine, Neil B Ruderman, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Frontiers in Nutrition|August 27, 2021
Dietary Control of Inflammation and ResolutionBarry Sears, Asish K Saha
Molecular and Cellular Biochemistry|November 19, 2003
Malonyl-CoA and AMP-activated protein kinase: an expanding partnershipAsish K Saha, Neil B Ruderman
Obesity (Silver Spring, Md.)|April 29, 2006
Metabolic syndrome: adenosine monophosphate-activated protein kinase and malonyl coenzyme ANeil B Ruderman, Asish K Saha
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry|May 13, 2020
Dietary Technologies to Optimize Healing from Injury-Induced InflammationBarry Sears, Mary Perry, Asish K Saha
Endocrinology|September 23, 2003
Minireview: malonyl CoA, AMP-activated protein kinase, and adiposityNeil B Ruderman, Asish K Saha, Edward W Kraegen
Diabetes/Metabolism Research and Reviews|July 12, 2002
Regulation of muscle malonyl-CoA levels in the nutritionally insulin-resistant desert gerbil, Psammomys obesusEleazar Shafrir, Ehud Ziv, Asish K Saha, et al.
Trends in Pharmacological Sciences|February 1, 2005
AMPK, the metabolic syndrome and cancerZhijun Luo, Asish K Saha, Xiaoqin Xiang, et al.
Diabetes|June 9, 2009
Activation of AMP-activated protein kinase by interleukin-6 in rat skeletal muscle: association with changes in cAMP, energy state, and endogenous fuel mobilizationMeghan Kelly, Marie-Soleil Gauthier, Asish K Saha, et al.
Journal of Endocrinology, Diabetes & Obesity|June 30, 2015
Nutrient Excess in AMPK Downregulation and Insulin ResistanceKimberly A Coughlan, Rudy J Valentine, Neil B Ruderman, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|July 15, 2014
AMPK activation: a therapeutic target for type 2 diabetes?Kimberly A Coughlan, Rudy J Valentine, Neil B Ruderman, et al.
Pageof 6